101 related articles for article (PubMed ID: 9287145)
1. CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A.
Rosato A; Zambon A; Milan G; Ciminale V; D'Agostino DM; Macino B; Zanovello P; Collavo D
Hum Gene Ther; 1997 Aug; 8(12):1451-8. PubMed ID: 9287145
[TBL] [Abstract][Full Text] [Related]
2. Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A.
Warnier G; Duffour MT; Uyttenhove C; Gajewski TF; Lurquin C; Haddada H; Perricaudet M; Boon T
Int J Cancer; 1996 Jul; 67(2):303-10. PubMed ID: 8760603
[TBL] [Abstract][Full Text] [Related]
3. Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy.
Rosato A; Zoso A; Milan G; Macino B; Dalla Santa S; Tosello V; Di Carlo E; Musiani P; Whalen RG; Zanovello P
J Immunol; 2003 Nov; 171(10):5172-9. PubMed ID: 14607917
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth.
Vandermeulen G; Uyttenhove C; De Plaen E; Van den Eynde BJ; Préat V
Bioelectrochemistry; 2014 Dec; 100():112-8. PubMed ID: 24342164
[TBL] [Abstract][Full Text] [Related]
5. Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815.
Bilsborough J; Van Pel A; Uyttenhove C; Boon T; Van den Eynde BJ
J Immunol; 1999 Mar; 162(6):3534-40. PubMed ID: 10092811
[TBL] [Abstract][Full Text] [Related]
6. Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene.
Colmenero P; Liljeström P; Jondal M
Gene Ther; 1999 Oct; 6(10):1728-33. PubMed ID: 10516722
[TBL] [Abstract][Full Text] [Related]
7. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815.
Van den Eynde B; Mazarguil H; Lethé B; Laval F; Gairin JE
Eur J Immunol; 1994 Nov; 24(11):2740-5. PubMed ID: 7525302
[TBL] [Abstract][Full Text] [Related]
8. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
Van den Eynde B; Lethé B; Van Pel A; De Plaen E; Boon T
J Exp Med; 1991 Jun; 173(6):1373-84. PubMed ID: 1903428
[TBL] [Abstract][Full Text] [Related]
9. The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection.
Brändle D; Bilsborough J; Rülicke T; Uyttenhove C; Boon T; Van den Eynde BJ
Eur J Immunol; 1998 Dec; 28(12):4010-9. PubMed ID: 9862337
[TBL] [Abstract][Full Text] [Related]
10. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.
Uyttenhove C; Godfraind C; Lethé B; Amar-Costesec A; Renauld JC; Gajewski TF; Duffour MT; Warnier G; Boon T; Van den Eynde BJ
Int J Cancer; 1997 Jan; 70(3):349-56. PubMed ID: 9033639
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
12. [Preventive and therapeutic effect of genetic vaccine based on recombinant alpha virus against mouse mastocytoma P815].
Ni B; Yang RG; Li YQ; Wu YZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):45-8. PubMed ID: 15182620
[TBL] [Abstract][Full Text] [Related]
13. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected.
Ramarathinam L; Sarma S; Maric M; Zhao M; Yang G; Chen L; Liu Y
J Immunol; 1995 Dec; 155(11):5323-9. PubMed ID: 7594546
[TBL] [Abstract][Full Text] [Related]
14. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
Brichard VG; Warnier G; Van Pel A; Morlighem G; Lucas S; Boon T
Eur J Immunol; 1995 Mar; 25(3):664-71. PubMed ID: 7705394
[TBL] [Abstract][Full Text] [Related]
15. Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A.
Markiewicz MA; Fallarino F; Ashikari A; Gajewski TF
Int Immunol; 2001 May; 13(5):625-32. PubMed ID: 11312250
[TBL] [Abstract][Full Text] [Related]
16. Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.
Näslund TI; Uyttenhove C; Nordström EK; Colau D; Warnier G; Jondal M; Van den Eynde BJ; Liljeström P
J Immunol; 2007 Jun; 178(11):6761-9. PubMed ID: 17513723
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
Schirmbeck R; Böhm W; Reimann J
J Immunol; 1996 Oct; 157(8):3550-8. PubMed ID: 8871655
[TBL] [Abstract][Full Text] [Related]
18. CD40 triggering increases the efficiency of dendritic cells for antitumoral immunization.
Mazouz N; Ooms A; Moulin V; Van Meirvenne S; Uyttenhove C; Degiovanni G
Cancer Immun; 2002 Mar; 2():2. PubMed ID: 12747747
[TBL] [Abstract][Full Text] [Related]
19. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
20. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide.
Lethé B; van den Eynde B; van Pel A; Corradin G; Boon T
Eur J Immunol; 1992 Sep; 22(9):2283-8. PubMed ID: 1381312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
